BST2 overexpression decreased RSV multiplication. by Katherine Marougka (13015146)

Diltiazem decreases the cell surface expression of ACE2. by Xinxin Wang (134010)

Ranked OD net percent decrease. by Jimy Pinto (4376539)

Cellular co-infection decreases the potential for superinfection. by Brigitte E. Martin (8366847)

Survival of infection decreases as initial dose increases. by Moria Cairns Chambers (7542080)

Claudin V is decreased following infection with Mtb. by Amanda S. Latham (12093638)

“…(N = 4–6 animals/ Mtb infection group; 2 animals in the cytosis⁺ group). …”

TLR agonists decrease ZIKV replication. by Fiorella Rossi (134126)

Decrease of HLA-DR expression is more pronounced in severe cases. by Sanja Matic (9931091)

Ifit2 deficiency results in decreased neuroinflammation upon RSA59 infection. by Jayasri Das Sarma (652473)

SOX2-KO decreases HCMV gene transcription. by Le Wen (14587872)

The specific infectivity of JEV RP9 is decreased after BBB-crossing. by Cécile Khou (10924907)

LSPC treatment decreases neuropathology in prion-infected mice. by Heather Bender (363996)

“…(B) In the hippocampus, we observed decreased PrP^Res, GFAP and vacuolation in responder and non-responder mice compared to infected untreated mice. …”

Decrease in VACV infectivity linked to defect in viral entry. by Lalita Priyamvada (421536)

HCV infection decreases L1 retrotransposition frequency. by Anja Schöbel (10668438)

The number of overrepresented short sequences decreases as infection progresses. by MiYao Hu (7865549)

IMP-1088 decreases infectivity of progeny VACV particles. by Lalita Priyamvada (421536)

Murine gastric pH decreases at peak infection. by Sarah E. Woodward (19429623)

Melanization potential decreases with higher temperature, aging, and infection. by Lindsay E. Martin (17377067)

Decreasing phagocytosis did not block NRF2 activation in <i>Lgy</i> infection. by Marta Reverte (10450927)

Decreased cytokine expression in J2.2-HKU1.7b-infected BMDM. by Chaminda D. Gunawardene (22794593)